RetinaCME
EXPERT VIDEOCMEABO MOC

Noninfectious Uveitis: Personalizing Treatment to Improve Outcomes

Author(s)/Faculty: Thomas A. Albini, MD; Sumit Sharma, MD
Release Date: 4/30/2020Expiration Date: 4/29/2021
Credit Type: CME / ABO MOCNumber of Credits: 0.75
Content Type: VideoProvider:
Noninfectious uveitis continues to be a leading cause of preventable blindness worldwide. Timely diagnosis and initiation of effective management regimens are imperative, but this can be challenging due to the diverse underlying causes of uveitis. The stepladder approach is utilized for the treatment of noninfectious uveitis, with corticosteroids being given as first-line therapy. However, adverse events associated with long-term administration of high-dose systemic corticosteroids has led to the development and approval of effective non-steroidal therapies, along with corticosteroid intraocular implants. Other therapies including biologics and gene therapy, for example, are also currently under clinical evaluation. In this educational activity, experts in the field discuss the incorporation of long-term management protocols, as well as review safety and efficacy data for new and emerging therapies that have demonstrated improved outcomes for patients with noninfectious uveitis.